DOTW examines how in 2013 Biotech Deal Stats Stack Up After Amgen / Onyx

DOTW examines how in 2013 Biotech Deal Stats Stack Up After Amgen / onyx The company also produces generic inflammatory pain reducer disalcid (salsa...


DOTW examines how in 2013 Biotech Deal Stats Stack Up After Amgen / onyx
The company also produces generic inflammatory pain reducer disalcid (salsalate) and the anti-anxiety drug Xanax (alprazolam). Endo need to provide more business development deals when it the revenue that will be lost is to makeup, …
Read more on in the vivo Blog (blog)

Leave a Reply